Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cost, Risk and Scientific Conservatism Dramatically Limit the Dealmaking for Heart Medicines.

Dec 01 2006

Related Content

FoxHollow and Merck Expand Alliance, Aim at Vulnerable Plaque

Oct 01 2006

Reconfiguring DTC with Patient Behavior in Mind

Oct 01 2002

Related Companies

Pfizer Inc.

AtheroGenics, Inc.

Abbott

Ionis Pharmaceuticals, Inc.

Merck & Co., Inc.

Additional Topics

Clinical Trials BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window